UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 250

Sortiert nach

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO

British journal of haematology, 2023-10, Vol.203 (2), p.202-211

2023

Volltextzugriff (PDF)

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

Cell death and differentiation, 2014-02, Vol.21 (2), p.247-257

2014

Volltextzugriff (PDF)

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment

Advances in Hematology, 2011, Vol.2011, p.142395-6

2011

Volltextzugriff (PDF)

Identification of MNDA as a new marker for nodal marginal zone lymphoma

Leukemia, 2009-10, Vol.23 (10), p.1847-1857

2009

Volltextzugriff (PDF)

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

Leukemia, 2012-10, Vol.26 (10), p.2159-2171

2012

Volltextzugriff (PDF)

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Leukemia, 2014-04, Vol.28 (4), p.823-829

2014

Volltextzugriff (PDF)

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

Leukemia, 2014-05, Vol.28 (5), p.1103-1112

2014

Volltextzugriff (PDF)

MicroRNA signatures in B-cell lymphomas

Blood cancer journal (New York), 2012-02, Vol.2 (2), p.e57-e57

2012

Volltextzugriff (PDF)

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

Leukemia, 2012-10, Vol.26 (10), p.2277-2285

2012

Volltextzugriff (PDF)

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

Haematologica (Roma), 2010-12, Vol.95 (12), p.2056-2062

2010

Volltextzugriff (PDF)

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

Annals of oncology, 2012-03, Vol.23 (3), p.729-735

2012

Volltextzugriff (PDF)

Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from the Spanish group GELTAMO

Hematological oncology, 2017-06, Vol.35 (S2), p.345-345

2017

Volltextzugriff (PDF)

Expression pattern of XBP1(S) in human B-cell lymphomas

Haematologica (Roma), 2009-03, Vol.94 (3), p.419-422

2009

Volltextzugriff (PDF)

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

Leukemia, 2010-04, Vol.24 (4), p.872-876

2010

Volltextzugriff (PDF)

PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH‐RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO

Hematological oncology, 2017-06, Vol.35 (S2), p.188-189

2017

Volltextzugriff (PDF)

A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages

Clinical cancer research, 2010-01, Vol.16 (2), p.637-650

2010

Volltextzugriff (PDF)

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

Haematologica (Roma), 2014-02, Vol.99 (2), p.222

2014

Volltextzugriff (PDF)

Exploring data processing strategies in NGS target enrichment to disentangle radiations in the tribe Cardueae (Compositae)

Molecular phylogenetics and evolution, 2018-11, Vol.128, p.69-87

2018

Volltextzugriff (PDF)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Haematologica (Roma), 2010-08, Vol.95 (8), p.1342-1349

2010

Volltextzugriff (PDF)

Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features

Haematologica (Roma), 2010-07, Vol.95 (7), p.1122-1129

2010

Volltextzugriff (PDF)

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

Haematologica (Roma), 2015-05, Vol.100 (5), p.e200

2015

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(131)
Humans
(127)
Female
(78)
Male
(73)
Middle Aged
(64)
Hematology
(56)
Pathology
(56)
Aged
(52)
Adult
(50)
Lymphoma
(44)
Biological And Medical Sciences
(38)
Medical Sciences
(38)
Immunohistochemistry
(37)
Prognosis
(37)
Oncology
(36)
Hematologic And Hematopoietic Diseases
(32)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(30)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(29)
Aged, 80 And Over
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(39)
Leukemia
(13)
Modern Pathology
(13)
British Journal Of Haematology
(12)
Haematologica
(12)
Histopathology
(12)
The American Journal Of Surgical Pathology
(10)
Clinical Lymphoma, Myeloma And Leukemia
(8)
Oncotarget
(8)
Clinical Cancer Research
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment

Identification of MNDA as a new marker for nodal marginal zone lymphoma

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

MicroRNA signatures in B-cell lymphomas

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from the Spanish group GELTAMO

Expression pattern of XBP1(S) in human B-cell lymphomas

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH‐RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO

A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

Exploring data processing strategies in NGS target enrichment to disentangle radiations in the tribe Cardueae (Compositae)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

Suchergebnisse filtern